These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10682872)

  • 21. Estrogen-induced small low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Obstet Gynecol; 1998 Feb; 91(2):234-40. PubMed ID: 9469282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions.
    Farish E; Spowart K; Barnes JF; Fletcher CD; Calder A; Brown A; Hart DM
    Atherosclerosis; 1996 Sep; 126(1):77-84. PubMed ID: 8879436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of small dense LDL concentration in Korean and Scottish men and women.
    Cho HK; Shin G; Ryu SK; Jang Y; Day SP; Stewart G; Packard CJ; Shepherd J; Caslake MJ
    Atherosclerosis; 2002 Sep; 164(1):187-93. PubMed ID: 12119209
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.
    Pontrelli L; Parris W; Adeli K; Cheung RC
    Metabolism; 2002 Mar; 51(3):334-42. PubMed ID: 11887170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surrogate lipid markers for small dense low-density lipoprotein particles in overweight youth.
    Burns SF; Lee SJ; Arslanian SA
    J Pediatr; 2012 Dec; 161(6):991-6. PubMed ID: 22809659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Lazzarini V; Fruzzetti F; Carmina E
    J Clin Endocrinol Metab; 2007 Jan; 92(1):186-9. PubMed ID: 17062762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LDL size and subclass pattern in a biethnic population.
    Haffner SM; Mykkänen L; Valdez RA; Paidi M; Stern MP; Howard BV
    Arterioscler Thromb; 1993 Nov; 13(11):1623-30. PubMed ID: 8218103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat.
    Greaves KA; Going SB; Fernandez ML; Milliken LA; Lohman TG; Bassford T; McNamara DJ
    Metabolism; 2003 Mar; 52(3):282-9. PubMed ID: 12647264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus.
    Niemeijer-Kanters SD; Dallinga-Thie GM; de Ruijter-Heijstek FC; Algra A; Erkelens DW; Banga JD; Jansen H
    Atherosclerosis; 2001 May; 156(1):209-16. PubMed ID: 11369016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of estrogen on susceptibility to oxidation of low-density and high-density lipoprotein in postmenopausal women.
    Wakatsuki A; Ikenoue N; Sagara Y
    Maturitas; 1998 Jan; 28(3):229-34. PubMed ID: 9571598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of nicotinic acid in subjects with different LDL subclass patterns.
    Superko HR; Krauss RM
    Atherosclerosis; 1992 Jul; 95(1):69-76. PubMed ID: 1642694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atherogenic lipoprotein phenotype and low-density lipoprotein size and subclasses in patients with growth hormone deficiency before and after short-term replacement therapy.
    Rizzo M; Trepp R; Berneis K; Christ ER
    Eur J Endocrinol; 2007 Mar; 156(3):361-7. PubMed ID: 17322496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic disorders contribute to subclinical coronary atherosclerosis in patients with coronary calcification.
    Superko HR; Hecht HS
    Am J Cardiol; 2001 Aug; 88(3):260-4. PubMed ID: 11472704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.